Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Translational Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1607638

Stereotactic Body Radiotherapy: A New Noninvasive Way to Conduct Pulmonary Artery Denervation?

Provisionally accepted
Manzhen  LiaoManzhen Liao1Taoyue  YaoTaoyue Yao2Yonghui  XieYonghui Xie3Shelby  KuttyShelby Kutty4Jinqiao  LiuJinqiao Liu2Wei  PengWei Peng1Ting  HuangTing Huang2Huaiyang  ChenHuaiyang Chen1Haoqin  FanHaoqin Fan2Zhenghui  XiaoZhenghui Xiao2Qiming  LiuQiming Liu5Yunbin  XiaoYunbin Xiao2*
  • 1Department of Pediatrics, Hengyang Medical College, University of South China, Hengyang, China
  • 2Hunan Children's Hospital, Changsha, Hunan Province, China
  • 3Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan Province, China
  • 4School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States
  • 5Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China

The final, formatted version of the article will be published soon.

BACKGROUND Pulmonary arterial hypertension is a severe and life-threatening disease characterized by a progressive increase in pulmonary vascular resistance. Catheter-based pulmonary artery denervation (PADN) has been conducted in pulmonary arterial hypertension patients, however, if stereotactic body radiotherapy (SBRT) can become a new noninvasive way to conduct PADN has not been elucidated.METHODS A total of 12 healthy male New Zealand rabbits were digitally marked on their foreheads and randomly divided into control group (n = 6) and SBRT group (n = 6) at a ratio of 1:1 using Computer-generated random numbers. In SBRT group, rabbits were treated with a single dose of 15 Gray, then bred for a minimum of 3 months. The rabbit models of acute thromboembolic pulmonary arterial hypertension (ATEPAH) were established by injecting autologous blood clots into the femoral vein. Right ventricular function and hemodynamics were assessed by echocardiography and right heart catheterization. Pulmonary artery sympathetic nerves were evaluated by pathological staining.RESULTS The SBRT procedure was successfully performed in all six rabbits. Compared to control group, SBRT-PADN reduced pulmonary artery systolic pressure and mean pulmonary artery pressure in ATEPAH rabbits. Meanwhile, SBRT-PADN could attenuate pulmonary artery dilatation in ATEPAH rabbits. Histological examination revealed evident structural damages in sympathetic nerves of SBRT-PADN animals, including vacuolization, nuclear pyknosis and digestion chambers. No adverse events had been observed, with sparing of pulmonary artery of the intima and media were detected up to 90 days post procedure.CONCLUSIONS SBRT could destroy sympathetic nerves around pulmonary artery locally, which may represent a novel option for performing PADN. Besides, this study proveded its short-term effectiveness and safety.

Keywords: pulmonary arterial hypertension, stereotactic body radiotherapy, pulmonary artery denervation, sympathetic nerves, Acute thromboembolic pulmonary arterial hypertension

Received: 07 Apr 2025; Accepted: 02 Jun 2025.

Copyright: © 2025 Liao, Yao, Xie, Kutty, Liu, Peng, Huang, Chen, Fan, Xiao, Liu and Xiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yunbin Xiao, Hunan Children's Hospital, Changsha, 410007, Hunan Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.